MedPath

Individuals on Hormone Therapy Breast Cancer Screening Pilot

Recruiting
Conditions
Breast Cancer
Registration Number
NCT06383026
Lead Sponsor
Medical College of Wisconsin
Brief Summary

This investigation is a prospective breast cancer screening study open to all individuals on hormone therapy. Using a mixed methods approach, the study will 1) gather prospective quantitative breast imaging data in conjunction with hormone therapy and family cancer history and 2) investigate individuals on hormone therapy perceptions and experiences in the breast cancer screening program, and 3) identify individual and systems-level barriers to breast cancer screening.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
130
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Callback and Biopsy Rates after Breast Cancer Screening3.5 years

Determine the callback and biopsy rates after screening imaging of the entire individuals on hormone therapy patient cohort who complete breast imaging exams.

Reflexive Thematic Analysis of the Physical, Cognitive, and Emotional Experience of Breast Cancer Screening in Individuals on Hormone Therapy3.5 years

Qualitative data utilized to identify themes around health beliefs, anxiety, and the breast cancer screening experience by describing the physical, cognitive, and emotional experience (perceived seriousness, perceived susceptibility, and anxiety) of individuals on hormone therapy cohort participants who complete surveys or participate in one-on-one interviews.

Reflexive Thematic Analysis on the Individual & System-Level Barriers to Breast Cancer Screening3.5 years

Qualitative date utilized to identify individual and healthcare systems-level barriers to breast cancer screening for individuals on hormone therapy who complete surveys and/or participate in one-on-one interviews and breast imaging faculty and staff who participate in focus groups.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical College of Wisconsin

πŸ‡ΊπŸ‡Έ

Milwaukee, Wisconsin, United States

Medical College of Wisconsin
πŸ‡ΊπŸ‡ΈMilwaukee, Wisconsin, United States
Chandler S Cortina, MD, MS
Contact
ccortina@mcw..edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.